Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide vs Mycophenolate in Lupus Nephritis
NCT04424602Phase 4Completed
- Sponsor
- Al-Azhar University
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide in lupus nephritis (LN), sponsored by Al-Azhar University. Started Apr 2021; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT04424602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04424602.